|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Bipolar I Depression | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Depression | |||||
| Depressive Disorder | |||||
| Depressive Disorder, Major | |||||
| 3 | More general conditions related to this trial | ||||
| Behavioral Symptoms | |||||
| Mental Disorders | |||||
| Mood Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| Armodafinil | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Modafinil | |||||
| 6 | More general drug interventions related to this trial | ||||
| Central Nervous System Agents | |||||
| Central Nervous System Stimulants | |||||
| Neuroprotective Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Cephalon | |||||